1-(3,4,5-Trimethoxyphenyl)prop-2-en-1-ol, 98%, 500mg

(E)-4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-2-one, 97%, 100mg

[5-(4-Trifluoromethoxy-phenyl)-[1,3,4]oxadiazol-2-ylmethyl]-carbamic acid tert-butyl ester, 95.0%, 1g

4-Picolinic acid ethyl ester, 99.00%, 25g

4,4-DIFLUORO-3,3-DIMETHYLPIPERIDINE HCL, 95.0%, 500mg

dmt-t, 95.0%, 100g

6-Bromo-5-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one, 97%, 250mg

1-N-Boc-4-Hydroxymethyl-piperidine, 97.0%, 500g

2-Bromo-3-chloroaniline, 98.0%, 5g

2-(4-Chlorophenyl)-2-morpholinoacetonitrile hydrochloride, 95.0%, 10g

5-Bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine, 95.0%, 1g

2-(Hydroxymethyl)-6-methoxyphenol, 95.0%, 25g

2-(2-Aminoéthylamino)éthanol, min. 98 %, pour la synthèse, 2,5 L, emballage en verre